Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors

IntroductionOpioid Use Disorder (OUD) is a severe and recurrent condition that contributes to a global prevalence of disabilities. Accumulating evidence suggests a potential convergence of clinical and genetic factors underlying OUD.ObjectivesThis study explores the clinical and genetic factors asso...

Full description

Saved in:
Bibliographic Details
Published in:European psychiatry 2024-08, Vol.67 (S1), p.S99-S99
Main Authors: Chamoun, K, F Hajj Moussa Lteif, Salameh, P, Sacre, H, Haddad, R, Rabbaa, L, Megarbane, B, Hajj, A
Format: Article
Language:English
Subjects:
Narcotics
Sociodemographics
Substance use disorder
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S99
container_issue S1
container_start_page S99
container_title European psychiatry
container_volume 67
creator Chamoun, K
F Hajj Moussa Lteif
Salameh, P
Sacre, H
Haddad, R
Rabbaa, L
Megarbane, B
Hajj, A
description IntroductionOpioid Use Disorder (OUD) is a severe and recurrent condition that contributes to a global prevalence of disabilities. Accumulating evidence suggests a potential convergence of clinical and genetic factors underlying OUD.ObjectivesThis study explores the clinical and genetic factors associated with OUD in the Lebanese population.MethodsA cross-sectional study in the Lebanese population included three different groups of participants stratified according to the cut-off of the revised Opioid Risk Tool (ORT-OUD): (1) Low-risk group for OUD (n=513; general population; ORT-OUD score
doi_str_mv 10.1192/j.eurpsy.2024.244
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9de369d8504d453dbadf8db35b7c9ade</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9de369d8504d453dbadf8db35b7c9ade</doaj_id><sourcerecordid>3097367870</sourcerecordid><originalsourceid>FETCH-LOGICAL-d1374-27cdf4036edbea3bfa7971b73d78301deceed5d6c9a75ea990f923c991aea6303</originalsourceid><addsrcrecordid>eNotjktLw0AUhQdRsFZ_gLsB16kzuUkm407qq1BQ0K7DTe6NnRIzcSZF-u8N1tXhPPg4QlxrtdDapre7Be_DEA-LVKXZIs2yEzHTxpQJ5GV-KmbKplliAcpzcRHjTiltlCpmon8dnHckN5Hlg4s-EAfpevmxDczyHb-GjqP0rRy3LNdcY8_T8s0P-w5H5_s7ufQh8NHIHzdu5bJzvWuwk9iTfOaeR9fIJ2xGH-KlOGuxi3z1r3OxeXr8WL4k69fn1fJ-nZAGkyWpaajNFBRMNSPULRprdG2ATAlKEzfMlFPRWDQ5o7WqtSk01mpkLEDBXKyOXPK4q4bgvjAcKo-u-gt8-KwwTL86riwxFJbKXGWU5UA1UltSDXltJvxUzsXNkTUE_73nOFY7vw_9dL8CZQ0UpjQKfgH84XdZ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3097367870</pqid></control><display><type>article</type><title>Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors</title><source>PubMed (Medline)</source><source>Cambridge University Press</source><creator>Chamoun, K ; F Hajj Moussa Lteif ; Salameh, P ; Sacre, H ; Haddad, R ; Rabbaa, L ; Megarbane, B ; Hajj, A</creator><creatorcontrib>Chamoun, K ; F Hajj Moussa Lteif ; Salameh, P ; Sacre, H ; Haddad, R ; Rabbaa, L ; Megarbane, B ; Hajj, A</creatorcontrib><description>IntroductionOpioid Use Disorder (OUD) is a severe and recurrent condition that contributes to a global prevalence of disabilities. Accumulating evidence suggests a potential convergence of clinical and genetic factors underlying OUD.ObjectivesThis study explores the clinical and genetic factors associated with OUD in the Lebanese population.MethodsA cross-sectional study in the Lebanese population included three different groups of participants stratified according to the cut-off of the revised Opioid Risk Tool (ORT-OUD): (1) Low-risk group for OUD (n=513; general population; ORT-OUD score &lt;2.5); (2) High-risk group for OUD (n=87; general population; ORT-OUD score ≥3); (3) a third group consisting of patients clinically diagnosed with OUD according to the DSM-5 (n=46). The survey included sociodemographic information and used validated scales to assess other substance use disorders, sleep disturbances, depression, and anxiety. Genotyping for the COMT, MTHFR, and CRY2 genes was conducted for 91 patients using a real-time PCR (Roche®). Bivariate and multivariate analyses were conducted to identify the associations between OUD risk and sociodemographic, clinical, and genetic factors.ResultsThis study enrolled 646 participants. Multivariate analysis showed significant associations between risk of developing an OUD and cigarette smoking (B=0.583), worse insomnia scores (B=0.074) and Alcohol, Smoking and Substance Involvement Screening Test-alcohol (B=0.053) scores, male gender (B=13.351), lack of education (B=4.159), unemployment (B=7.235), low income (B=11.285), lack of healthcare coverage (B=4.190), neuropsychiatric disorders (B=7.966). Conversely, OUD risk was negatively correlated with the morning chronotype (B=-0.372). Bivariate analysis showed that the CRY2 AA genotype was significantly associated with a higher risk of OUD; nevertheless, none of the genetic factors remained significant in the multivariable model.ConclusionsThis study identified several sociodemographic, clinical, and genetic factors that could potentially increase the risk of developing OUD in the Lebanese population. Further research is needed to clarify risk factors and underlying mechanisms, enabling the development of more effective prevention strategies.Disclosure of InterestNone Declared</description><identifier>ISSN: 0924-9338</identifier><identifier>EISSN: 1778-3585</identifier><identifier>DOI: 10.1192/j.eurpsy.2024.244</identifier><language>eng</language><publisher>Paris: Cambridge University Press</publisher><subject>Narcotics ; Sociodemographics ; Substance use disorder</subject><ispartof>European psychiatry, 2024-08, Vol.67 (S1), p.S99-S99</ispartof><rights>The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association. This work is licensed under the Creative Commons Attribution License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Chamoun, K</creatorcontrib><creatorcontrib>F Hajj Moussa Lteif</creatorcontrib><creatorcontrib>Salameh, P</creatorcontrib><creatorcontrib>Sacre, H</creatorcontrib><creatorcontrib>Haddad, R</creatorcontrib><creatorcontrib>Rabbaa, L</creatorcontrib><creatorcontrib>Megarbane, B</creatorcontrib><creatorcontrib>Hajj, A</creatorcontrib><title>Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors</title><title>European psychiatry</title><description>IntroductionOpioid Use Disorder (OUD) is a severe and recurrent condition that contributes to a global prevalence of disabilities. Accumulating evidence suggests a potential convergence of clinical and genetic factors underlying OUD.ObjectivesThis study explores the clinical and genetic factors associated with OUD in the Lebanese population.MethodsA cross-sectional study in the Lebanese population included three different groups of participants stratified according to the cut-off of the revised Opioid Risk Tool (ORT-OUD): (1) Low-risk group for OUD (n=513; general population; ORT-OUD score &lt;2.5); (2) High-risk group for OUD (n=87; general population; ORT-OUD score ≥3); (3) a third group consisting of patients clinically diagnosed with OUD according to the DSM-5 (n=46). The survey included sociodemographic information and used validated scales to assess other substance use disorders, sleep disturbances, depression, and anxiety. Genotyping for the COMT, MTHFR, and CRY2 genes was conducted for 91 patients using a real-time PCR (Roche®). Bivariate and multivariate analyses were conducted to identify the associations between OUD risk and sociodemographic, clinical, and genetic factors.ResultsThis study enrolled 646 participants. Multivariate analysis showed significant associations between risk of developing an OUD and cigarette smoking (B=0.583), worse insomnia scores (B=0.074) and Alcohol, Smoking and Substance Involvement Screening Test-alcohol (B=0.053) scores, male gender (B=13.351), lack of education (B=4.159), unemployment (B=7.235), low income (B=11.285), lack of healthcare coverage (B=4.190), neuropsychiatric disorders (B=7.966). Conversely, OUD risk was negatively correlated with the morning chronotype (B=-0.372). Bivariate analysis showed that the CRY2 AA genotype was significantly associated with a higher risk of OUD; nevertheless, none of the genetic factors remained significant in the multivariable model.ConclusionsThis study identified several sociodemographic, clinical, and genetic factors that could potentially increase the risk of developing OUD in the Lebanese population. Further research is needed to clarify risk factors and underlying mechanisms, enabling the development of more effective prevention strategies.Disclosure of InterestNone Declared</description><subject>Narcotics</subject><subject>Sociodemographics</subject><subject>Substance use disorder</subject><issn>0924-9338</issn><issn>1778-3585</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNotjktLw0AUhQdRsFZ_gLsB16kzuUkm407qq1BQ0K7DTe6NnRIzcSZF-u8N1tXhPPg4QlxrtdDapre7Be_DEA-LVKXZIs2yEzHTxpQJ5GV-KmbKplliAcpzcRHjTiltlCpmon8dnHckN5Hlg4s-EAfpevmxDczyHb-GjqP0rRy3LNdcY8_T8s0P-w5H5_s7ufQh8NHIHzdu5bJzvWuwk9iTfOaeR9fIJ2xGH-KlOGuxi3z1r3OxeXr8WL4k69fn1fJ-nZAGkyWpaajNFBRMNSPULRprdG2ATAlKEzfMlFPRWDQ5o7WqtSk01mpkLEDBXKyOXPK4q4bgvjAcKo-u-gt8-KwwTL86riwxFJbKXGWU5UA1UltSDXltJvxUzsXNkTUE_73nOFY7vw_9dL8CZQ0UpjQKfgH84XdZ</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Chamoun, K</creator><creator>F Hajj Moussa Lteif</creator><creator>Salameh, P</creator><creator>Sacre, H</creator><creator>Haddad, R</creator><creator>Rabbaa, L</creator><creator>Megarbane, B</creator><creator>Hajj, A</creator><general>Cambridge University Press</general><scope>DOA</scope></search><sort><creationdate>20240801</creationdate><title>Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors</title><author>Chamoun, K ; F Hajj Moussa Lteif ; Salameh, P ; Sacre, H ; Haddad, R ; Rabbaa, L ; Megarbane, B ; Hajj, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d1374-27cdf4036edbea3bfa7971b73d78301deceed5d6c9a75ea990f923c991aea6303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Narcotics</topic><topic>Sociodemographics</topic><topic>Substance use disorder</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chamoun, K</creatorcontrib><creatorcontrib>F Hajj Moussa Lteif</creatorcontrib><creatorcontrib>Salameh, P</creatorcontrib><creatorcontrib>Sacre, H</creatorcontrib><creatorcontrib>Haddad, R</creatorcontrib><creatorcontrib>Rabbaa, L</creatorcontrib><creatorcontrib>Megarbane, B</creatorcontrib><creatorcontrib>Hajj, A</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>European psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chamoun, K</au><au>F Hajj Moussa Lteif</au><au>Salameh, P</au><au>Sacre, H</au><au>Haddad, R</au><au>Rabbaa, L</au><au>Megarbane, B</au><au>Hajj, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors</atitle><jtitle>European psychiatry</jtitle><date>2024-08-01</date><risdate>2024</risdate><volume>67</volume><issue>S1</issue><spage>S99</spage><epage>S99</epage><pages>S99-S99</pages><issn>0924-9338</issn><eissn>1778-3585</eissn><abstract>IntroductionOpioid Use Disorder (OUD) is a severe and recurrent condition that contributes to a global prevalence of disabilities. Accumulating evidence suggests a potential convergence of clinical and genetic factors underlying OUD.ObjectivesThis study explores the clinical and genetic factors associated with OUD in the Lebanese population.MethodsA cross-sectional study in the Lebanese population included three different groups of participants stratified according to the cut-off of the revised Opioid Risk Tool (ORT-OUD): (1) Low-risk group for OUD (n=513; general population; ORT-OUD score &lt;2.5); (2) High-risk group for OUD (n=87; general population; ORT-OUD score ≥3); (3) a third group consisting of patients clinically diagnosed with OUD according to the DSM-5 (n=46). The survey included sociodemographic information and used validated scales to assess other substance use disorders, sleep disturbances, depression, and anxiety. Genotyping for the COMT, MTHFR, and CRY2 genes was conducted for 91 patients using a real-time PCR (Roche®). Bivariate and multivariate analyses were conducted to identify the associations between OUD risk and sociodemographic, clinical, and genetic factors.ResultsThis study enrolled 646 participants. Multivariate analysis showed significant associations between risk of developing an OUD and cigarette smoking (B=0.583), worse insomnia scores (B=0.074) and Alcohol, Smoking and Substance Involvement Screening Test-alcohol (B=0.053) scores, male gender (B=13.351), lack of education (B=4.159), unemployment (B=7.235), low income (B=11.285), lack of healthcare coverage (B=4.190), neuropsychiatric disorders (B=7.966). Conversely, OUD risk was negatively correlated with the morning chronotype (B=-0.372). Bivariate analysis showed that the CRY2 AA genotype was significantly associated with a higher risk of OUD; nevertheless, none of the genetic factors remained significant in the multivariable model.ConclusionsThis study identified several sociodemographic, clinical, and genetic factors that could potentially increase the risk of developing OUD in the Lebanese population. Further research is needed to clarify risk factors and underlying mechanisms, enabling the development of more effective prevention strategies.Disclosure of InterestNone Declared</abstract><cop>Paris</cop><pub>Cambridge University Press</pub><doi>10.1192/j.eurpsy.2024.244</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0924-9338
ispartof European psychiatry, 2024-08, Vol.67 (S1), p.S99-S99
issn 0924-9338
1778-3585
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9de369d8504d453dbadf8db35b7c9ade
source PubMed (Medline); Cambridge University Press
subjects Narcotics
Sociodemographics
Substance use disorder
title Opioid Use Disorder in Three Samples of the Lebanese Population: Correlation with Clinical and Genetic Factors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A41%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Opioid%20Use%20Disorder%20in%20Three%20Samples%20of%20the%20Lebanese%20Population:%20Correlation%20with%20Clinical%20and%20Genetic%20Factors&rft.jtitle=European%20psychiatry&rft.au=Chamoun,%20K&rft.date=2024-08-01&rft.volume=67&rft.issue=S1&rft.spage=S99&rft.epage=S99&rft.pages=S99-S99&rft.issn=0924-9338&rft.eissn=1778-3585&rft_id=info:doi/10.1192/j.eurpsy.2024.244&rft_dat=%3Cproquest_doaj_%3E3097367870%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d1374-27cdf4036edbea3bfa7971b73d78301deceed5d6c9a75ea990f923c991aea6303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3097367870&rft_id=info:pmid/&rfr_iscdi=true